📰 Emergent Biosolution News
Page 2 - Emergent Biosolution News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Emergent Biosolution. Real-time updates on events, politics, business and more.
September 19, 2023
Drug stores in Philadelphia, and across the country, began stocking bright pink boxes of Narcan earlier this month.
September 18, 2023
Access to Narcan, a lifesaving drug that reverses overdoses, has been limited by Emergent BioSolutions’ hunt for profits, including a five-year delay in…
September 13, 2023
WASHINGTON (TNS) — During the same week that naloxone — a nasal spray that reverses opioid overdoses — became available for purchase without a prescription, the nation’s top substance use
August 31, 2023
WEDNESDAY, Aug. 30, 2023 (HealthDay News) -- Narcan, a lifesaving medication that reverses opioid overdose, will be available on U.S. drugstore shelves and online starting next week.
August 31, 2023
Welcome to the MassDevice Fast Five medtech news podcast Here’s what you need to know for today, August 31, 2023.
August 30, 2023
Emergent’s name-brand Narcan was FDA-approved in March, and was the first-ever naloxone product to be approved for use without a prescription in the U.S.
August 30, 2023
WEDNESDAY, Aug. 30, 2023 (HealthDay News) -- Narcan, a lifesaving medication that reverses opioid overdose, will be available on U.S. drugstore shelves and online starting next week.
August 30, 2023
Narcan, a lifesaving medication that reverses opioid overdose, will be available on U.S. drugstore shelves and online starting next week.
August 30, 2023
Narcan, a lifesaving medication that reverses opioid overdose, will be available on U.S. drugstore shelves and online starting next week.
August 23, 2023
Hepion Pharmaceuticals (NASDAQ:HEPA – Get Free Report) and Emergent BioSolutions (NYSE:EBS – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, profitability and risk. Analyst Recommendations This is a summary of […]